Research institute for biological safety problems
Clinical trials of the QazCovid-in vaccine against coronavirus infection developed at the Research Institute of Biological Safety Problems of the Committee of Science MES RK have begun. The Ministry of…
On September 16, 2020, a round table was held at the Institute to discuss the Message of the President of the Republic of Kazakhstan Kassym-Jomart Tokayev “Kazakhstan in a new…
The Research Institute for Biological Safety Problems of the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (RIBSP) is recruiting volunteers who will take…
The World Health Organization (WHO) has officially included our domestic inactivated vaccine, developed by scientists of our Institute, into the list of vaccines approved for clinical trials. Kazakhstan vaccine with…
Preclinical studies of the Kazakhstan inactivated COVID-19 vaccine developed by the Research Institute for Biological Safety Problems (RIBSP) of SC MES RK on the basis of the pharmacological testing laboratory…
In early June this year, the Prime Minister of the Republic of Kazakhstan Askar Uzakpaevich Mamin visited the RSE ” Research Institute for Biological Safety Problems” of the Science Committee…
At the Scientific Research Institute for Biological Safety Problems of the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (hereinafter – RIBSP), on July…
On August 03, 2020 Akim of Zhambyl region Saparbayev B.M. accompanied by the Akim of the Kordai region and other representatives of the akimats of the Zhambyl oblast, the Kordai…
On July 31, 2020, the second Kazakhstan vaccine of the RSE “Research Institute for Biological Safety Problems” of the SC MES RK was successfully registered on the website of the…
On July 28, 2020, within the framework of international cooperation, an online video conference was held between the RSE RIBSP MES RK and the DUKE-NUS School of Medicine (Singapore). The…